Emerging Trends to Reshape the Gastrointestinal Bleeding Treatment Devices Market: Increasing Number Of Product Approvals as a Key Influencer

Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.

Gastrointestinal Bleeding Treatment Devices Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market for devices used in the treatment of gastrointestinal bleeding has seen substantial growth in the past few years. It is projected to increase from $0.87 billion in 2024 to $0.93 billion in 2025, with a compound annual growth rate (CAGR) of 6.1%. The growth during the historical period can be attributed to factors such as the aging population, changes in lifestyle, improvements in healthcare infrastructure, prevalence of gastrointestinal disorders, and advancements in endoscopy techniques.

Gastrointestinal Bleeding Treatment Devices Market Size Forecast: What's the Projected Valuation by 2029?
In the forthcoming years, the market for gastrointestinal bleeding treatment devices is predicted to experience significant expansion, reaching a value of $1.3 billion by 2029 with a compound annual growth rate (CAGR) of 8.9%. Functional catalysts promoting growth for the expected period include a focus on patient-oriented care, regulatory modifications, deployment of telemedicine and remote consultations, a surge in gastrointestinal maladies and healthcare investments. The significant tendencies projected for the forecast period comprise non-invasive diagnostic technologies, precision medicine, remote surveillance and telehealth, along with advances in artificial intelligence and machine learning.

View the full report here:
https://www.thebusinessresearchcompany.com/report/gastrointestinal-bleeding-treatment-devices-global-market-report

What Are the Drivers Transforming the Gastrointestinal Bleeding Treatment Devices Market?
Expected growth in the gastrointestinal bleeding treatment devices market is likely due to an increase in occurrences of upper gastrointestinal bleeding over the forecast period. The upper gastrointestinal bleeding, which arises in the esophagus, stomach, or upper section of the small intestine, can result from causes including peptic ulcers, esophagitis, enteritis, gastritis, cancer, among others. For example, the National Institute for Health and Care Excellence reports that in the UK, the incidence rate of acute upper GI bleeding is between 84-172 per 100,000 people annually. Additionally, according to a 2023 study published in the National Library of Medicine - National Institutes of Health, the in-hospital death rates for upper GI bleeding sits around 10%. This rate stays stable up to a month post-hospitalization for GI bleed. On a longer-term basis, all-cause mortality rates rise to nearly 37% in the three years following admission.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=5307&type=smp

What Long-Term Trends Will Define the Future of the Gastrointestinal Bleeding Treatment Devices Market?
Big enterprises in the field of gastrointestinal bleeding treatment devices are concentrating on innovating advanced solutions like the EVIS X1 endoscopy system, with the aim of boosting diagnostic precision, enhancing patient results, and creating efficient clinical processes. Created as an advanced endoscopic imaging platform, the EVIS X1 endoscopy system aims to augment diagnostic efficiency and treatment interventions across a multitude of medical fields such as gastroenterology, pulmonology, and urology. Olympus Corporation, a medical and surgical technologies firm based in Japan, rolled out its latest EVIS X1 endoscopy system in November 2023. This next-generation EVIS X1 endoscopy system reinvents endoscopic imaging technology, striving to boost diagnostic capabilities, streamline procedural operations and enable improved clinical outcomes. This novel version of EVIS X1 is enhanced with sophisticated imaging techniques, intuitive interfaces, and artificial intelligence (AI) assistance to cater to a broad spectrum of medical applications, especially in gastroenterology and pulmonology.

Which Segments in the Gastrointestinal Bleeding Treatment Devices Market Offer the Most Profit Potential?
The gastrointestinal bleeding treatment devices market covered in this report is segmented -

1) By Product: Endoscopic Thermal Devices, Other Products
2) By GI Tract Division: Upper GI Tract, Lower GI Tract
3) By End User: Hospitals Or Clinics, Ambulatory Surgical Centers, Other End-users

Subsegments:
1) By Endoscopic Thermal Devices: Radiofrequency Ablation Devices, Laser Therapy Devices, Coagulation Devices
2) By Other Products: Hemostatic Clips, Injection Devices, Mechanical Hemostatic Devices

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=5307&type=smp

Which Firms Dominate the Gastrointestinal Bleeding Treatment Devices Market by Market Share and Revenue in 2025?
Major companies operating in the gastrointestinal bleeding treatment devices market include CONMED Corporation, Boston Scientific Corporation, Ovesco Endoscopy AG, Olympus Corporation, Cook Medical, Erbe Elektromedizin GmbH, Steris plc., Medtronic, Johnson & Johnson, Abbott Laboratories, Fujifilm Holdings Corporation, Pentax Medical, Merit Medical Systems, Teleflex Incorporated, AngioDynamics, BTG International Ltd., Medline Industries Inc. Smiths Medical, Terumo Corporation, Nipro Corporation, ConvaTec Group PLC, Coloplast A/S, Hollister Incorporated, Wellspect HealthCare, C. R. Bard Inc., EndoChoice Holdings Inc., GI Supply Inc., Hemostasis LLC

Which Regions Offer the Highest Growth Potential in the Gastrointestinal Bleeding Treatment Devices Market?
North America was the largest region in the gastrointestinal bleeding treatment devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastrointestinal bleeding treatment devices market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=5307

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Learn More About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.